[Management of pulmonary recurrence of hepatocellular carcinoma after receiving a living-donor liver transplantation--a case report].
We report on the treatment experience of five living-donor liver transplantation (LDLT) recipients for hepatocellular carcinoma (HCC) with pulmonary metastases. Between March 1998 and December 2007, five patients who underwent LDLT for HCC were identified with a routine follow-up of pulmonary metastases: Two patients underwent a radical resection for pulmonary recurrence of HCC, Two patients were only observed by palliative treatment, and one patient had chemotherapy using S-1/IFN. The survival range from pulmonary recurrence of HCC was 7.5 to 43.0 months and the median survival time was 18.9 months. Only one of the 5 patients who underwent a surgical resection of pulmonary recurrence is still alive without a new recurrence for a long period of time.
Asaoka
Tadafumi
T
Dept. of Surgery, Graduate School of Medicine, Osaka University.
Marubashi
Shigeru
S
Dono
Keizo
K
Hama
Naoki
N
Kim
Chiwan
C
Kobayashi
Shogo
S
Takeda
Yutaka
Y
Nagano
Hiroaki
H
Umeshita
Koji
K
Monden
Morito
M
Doki
Yuichiro
Y
Mori
Masaki
M
D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery*; D016031:Liver Transplantation; D019520:Living Donors; D008175:Lung Neoplasms / Q000556:secondary* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012008:Recurrence